Opdivo Qvantig

Active Ingredient(s): Nivolumab + Hyaluronidase
FDA Approved: * December 27, 2024
Pharm Company: * BRISTOL-MYERS SQUIBB
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Opdivo Qvantig Subcutaneous Injection, Solution
NDC: 0003-6120
Labeler:
E.r. Squibb & Sons, L.L.C.

Popular Topics

Opdivo (nivolumab) reviews

I had stage 3b subungual melanoma and after they did an amputation of my thumb and lymph nodes dissection, they lowered ...

4 REPLIES